1. Batista R, Vinagre N, Meireles S, Vinagre J, Prazeres H, Leão R, Máximo V, Soares P

Biomarkers for Bladder Cancer Diagnosis and Surveillance: A Comprehensive Review. Diagnostics (Basel, Switzerland) 10: ., 2020. [Review] 

 doi: 10.3390/diagnostics10010039 PMID: 31941070.

 

2. Batista R, Lima L, Vinagre J, Pinto V, Lyra J, Máximo V, Santos L, Soares P

TERT Promoter Mutation as a Potential Predictive Biomarker in BCG-Treated Bladder Cancer Patients. International journal of molecular sciences 21: ., 2020. [Article] 

 doi: 10.3390/ijms21030947 PMID: 32023888.

 

3. Batista R, Vinagre J, Prazeres H, Sampaio C, Peralta P, Conceição P, Sismeiro A, Leão R, Gomes A, Furriel F, Oliveira C, Torres JN, Eufrásio P, Azinhais P, Almeida F, Gonzalez ER, Bidovanets B, Ecke T, Stinjs P, Pascual ÁS, Abdelmalek R, Villafruela A, Beardo-Villar P, Fidalgo N, Öztürk H, Gonzalez-Enguita C, Monzo J, Lopes T, Álvarez-Maestro M, Servan PP, De La Cruz SMP, Perez MPS, Máximo V, Soares P

Validation of a Novel, Sensitive, and Specific Urine-Based Test for Recurrence Surveillance of Patients With Non-Muscle-Invasive Bladder Cancer in a Comprehensive Multicenter Study. Frontiers in genetics 10: 1237, 2019. [Article] 

 doi: 10.3389/fgene.2019.01237 PMID: 31921291.

 

4. Batista R, Gaspar TB, Soares P, Vinagre J

Editorial on "The genomic landscape of TERT promoter wildtype-IDH wildtype glioblastoma" TRANSLATIONAL CANCER RESEARCH 7: S762-S765, 2018. [Editorial Material] 

 doi: 10.21037/tcr.2018.08.06.

 

5. Batista R, Cruvinel-Carloni A, Vinagre J, Peixoto J, Catarino TA, Campanella NC, Menezes W, Becker AP, de Almeida GC, Matsushita MM, Clara C, Neder L, Viana-Pereira M, Honavar M, Castro L, Lopes JM, Carvalho B, Vaz RM, Máximo V, Soares P, Sobrinho-Simões M, Reis RM, Lima J

The prognostic impact of TERT promoter mutations in glioblastomas is modified by the rs2853669 single nucleotide polymorphism. International journal of cancer 139: 414-23, 2016. [Article] 

 doi: 10.1002/ijc.30057 PMID: 26914704.